News

Melbourne, 19 September 2024 -- Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies™, a pioneer in agricultural genomics, today announced a strategic partnership to accelerate the adoption of genomics in agricultural applications.

LGC appoints Dr Alexander Zahiri as Executive Vice President & General Manager, Axolabs

LGC appoints Marcus Kaeller as Chief Financial Officer

Pioneering Cancer Treatments through Enhanced Genomic Profiling in the GenomeMET Project

The National Measurement Laboratory and UK NEQAS for Leucocyte Immunophenotyping announce collaboration to improve quality assessment schemes for Chronic Myeloid Leukaemia Minimal Residual Disease testing.

New laboratory officially opened by David Willetts, UK Minister for Universities and Science.

LGC Biosearch Technologies™ launches a groundbreaking nucleic acid extraction method, sbeadex™ Lightning. This groundbreaking product rapidly delivers high-purity DNA in high-yields, typically achieving results in 5 minutes

LGC announces half year trading results

LGC acquires PolyDesign, a provider of innovative oligo solid support products for life sciences customers.  

National Measurement Laboratory at LGC supports the UK global leadership in ensuring accurate diagnostics for future pandemics.

LGC Clinical Diagnostics, a business unit of LGC, today announced the acquisition of Virusys Corporation, a developer and manufacturer of monoclonal antibodies and viral antigens.

LGC announced today the appointment of David P. King as Non-Executive Chairman of its Board of Directors.